Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Feb 22, 2024 9:16pm
96 Views
Post# 35894790

RE:RE:RE:RE:RE:RE:RE:ONCY accumulated deficit (Tax losses applied to a buyout)

RE:RE:RE:RE:RE:RE:RE:ONCY accumulated deficit (Tax losses applied to a buyout)
No problem and you can read it how you want but from the last line of the article you posted.

The benefit is that it lowers the taxable income in the second year to $2.4 million.

Quite simply stating that it lowers the taxable income and you pay tax on the bracket that applies to you or your company.

Bottom line is that there is value to the accumulated amazingly large deficit but it is in Canadian dollars and not as much as you think as honestly I too would like to do accounting the way you do as that would increase the implied value of onc by double of any tax write off and really wish it was worth the 5 U.S.




<< Previous
Bullboard Posts
Next >>